CPHI Worldwide 2025

Enzene will be participating in CPHI Worldwide 2025 and welcomes the opportunity to engage with global partners exploring CDMO services and biosimilar collaborations.

Join us at this premier event to:

• Discuss your biologics and biosimilar development and manufacturing strategies
• Learn how Enzene’s agile, full-spectrum CDMO model can accelerate your product’s path to market
• Explore our expanding portfolio of biosimilars available for licensing and strategic partnerships across international markets

We invite you to schedule a meeting at CPHI 2025 to discover how Enzene can support your development, manufacturing, and commercialization goals globally.”